综合分布性成本效益分析:一种新的卫生经济评估工具,用于为资源分配提供信息
Shan Jiang1, Boyang Li2, Bonny Parkinson3
1Macquarie University Centre for the Health Economy, Macquarie Business School and Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia. shan.jiang@mq.edu.au.
综合分布性成本效益分析 (A-DCEA) 提供了一种评估医疗干预公平性的实用方法. 这种方法有助于决策者通过考虑健康公平来做出明智的决策,特别是当详细数据有限时.
科学领域:
- 卫生经济学 卫生经济学
- 公共卫生政策 公共卫生政策
- 卫生公平研究 卫生公平研究
背景情况:
- 传统的成本效益分析 (CEA) 往往忽视了健康公平,专注于平均结果.
- 需要方法来量化卫生干预措施对健康公平的影响.
- 分布性成本效益分析 (DCEA) 为评估这些影响提供了一个框架.
研究的目的:
- 引入综合分布性成本效益分析 (A-DCEA) 作为评估医疗干预公平性的务实工具.
- 证明A-DCEA对政策决策的有用性,特别是当没有完整的DCEA的详细子组数据时.
- 促进将公平考虑纳入医疗保健决策过程.
主要方法:
- A-DCEA是作为完全DCEA的简化替代品而提出的.
- 它利用聚合数据,使其更容易获得和可用于更广泛的应用.
- 评论概述了A-DCEA的理由,实施步骤和适用性.
主要成果:
- A-DCEA提供了一种实用且易于使用的方法来评估卫生干预措施的分布影响.
- 它使决策者能够将公平考虑纳入决策过程.
- 该方法支持有效利用资源,同时解决健康不平等问题.
结论:
- A-DCEA是促进医疗保健决策中的健康公平的一个有价值的工具.
- 它的采用可以带来更明智的健康政策,解决不平等问题.
- A-DCEA增强了以公平为中心的健康经济评估的实际应用.
更多相关视频
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Analysis of Population Pharmacokinetic Data
Statistical Methods for Analyzing Epidemiological Data
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Hazard Ratio
For example, in a clinical trial...
